ArticlePloS one2010

beta-TrCP inhibition reduces prostate cancer cell growth via upregulation of the aryl hydrocarbon receptor.

Udi Gluschnaider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.